Branded Zantac Makers Can’t Escape Class-Action, Judge Rules
MedTruth Editors · October 21, 2021
Zantac manufacturers are facing lawsuits filed by individuals who claim the drug causes cancer.
Legal DevelopmentsBest Results for “Zantac”
Dates Set for First Zantac Trials in the Nation
MedTruth Editors · September 29, 2021
The first Zantac cancer case has been scheduled for 2022.
Legal DevelopmentsZantac MDL Judge Reduces Relevant Defendants
MedTruth Editors · August 17, 2021
Judge Rosenberg determined that the lawsuits against the generic manufacturer are preempted since the law does not allow the generics to be labeled differently.
Legal DevelopmentsBranded Zantac Makers Can’t Escape Class-Action, Judge Rules
MedTruth Editors · October 21, 2021
Zantac manufacturers are facing lawsuits filed by individuals who claim the drug causes cancer.
Legal DevelopmentsDates Set for First Zantac Trials in the Nation
MedTruth Editors · September 29, 2021
The first Zantac cancer case has been scheduled for 2022.
Legal DevelopmentsZantac MDL Judge Reduces Relevant Defendants
MedTruth Editors · August 17, 2021
Judge Rosenberg determined that the lawsuits against the generic manufacturer are preempted since the law does not allow the generics to be labeled differently.
Legal Developments
Lawsuit Information
Zantac and its generic forms have been linked to cancers by numerous patients in ongoing lawsuits.
Most Recent Results for “Zantac”
California Attorneys Seek to Consolidate Zantac Lawsuits
James Parker · June 12, 2020
Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.
Legal DevelopmentsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsP&G Old Spice & Secret Products Recalled Over Benzene
MedTruth Editors · December 13, 2021
Old Spice men’s cologne and Secret deodorant aerosol cans were found to have detectable levels of benzene, a known human carcinogen that may cause cancer.
NewsBranded Zantac Makers Can’t Escape Class-Action, Judge Rules
MedTruth Editors · October 21, 2021
Zantac manufacturers are facing lawsuits filed by individuals who claim the drug causes cancer.
Legal DevelopmentsDates Set for First Zantac Trials in the Nation
MedTruth Editors · September 29, 2021
The first Zantac cancer case has been scheduled for 2022.
Legal DevelopmentsZantac MDL Judge Reduces Relevant Defendants
MedTruth Editors · August 17, 2021
Judge Rosenberg determined that the lawsuits against the generic manufacturer are preempted since the law does not allow the generics to be labeled differently.
Legal DevelopmentsMore Recalls Issued for Diabetes Drug Metformin
Nicole Knight · October 15, 2020
The FDA has announced two additional voluntary recalls of extended-release metformin.
FDA RegulationFDA Issues Guidance on Drug Impurities
MedTruth Editors · September 8, 2020
The FDA announced new guidance on Sept. 1 for drugmakers, citing “serious concerns” about common medications.
FDA RegulationDrug Companies Investigated for Possible Failure to Disclose Zantac Cancer Risks
MedTruth Editors · September 1, 2020
The U.S. Department of Justice is investigating whether drugmakers violated the False Claims Act by possibly failing to disclose the presence of NDMA in their Zantac and generic ranitidine heartburn products.
NewsCalifornia Attorneys Seek to Consolidate Zantac Lawsuits
James Parker · June 12, 2020
Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.
Legal DevelopmentsCanadian Drug Co. Apotex Recalls Metformin Due to NDMA Contamination
MedTruth Editors · May 29, 2020
Metformin was voluntarily recalled after N-Nitrosodimethylamine (NDMA) was discovered in a single lot of Apotex’s product.
FDA RegulationPepcid Shows Promise Against COVID-19
Joanna Shawn Brigid O'Leary · May 28, 2020
The active ingredient in Pepcid heartburn medication, famotidine, may be an effective treatment for the coronavirus.
Research + FindingsZantac and Ranitidine Products Removed from U.S. Market
Ashley Lombardo · April 1, 2020
On April 1, the U.S. Food and Drug Administration requested immediate removal of Zantac products from the U.S. market, including all prescription and over-the-counter medications containing ranitidine.
NewsCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal DevelopmentsCanada Faces a Zantac Alternatives Shortage
Benjamin Duong · February 11, 2020
Canada is facing shortages of heartburn medications after a Zantac recall led to an increase in demand for alternatives.
News5 Powerful Quotes About Patient Safety by Congresswoman Rosa DeLauro
Carah Wertheimer · January 28, 2020
Congresswoman Rosa DeLauro has fought for equal pay for women, the creation of middle-class jobs, and wellbeing for veterans, along with public health and patient safety issues.
Health FeaturesBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsFDA Metformin Probe Investigates Potential NDMA Hazard
James Parker · January 8, 2020
An investigation will determine whether the diabetes drug metformin contains dangerously elevated levels of the carcinogen NDMA, as part of a larger movement to examine a wide spectrum of medications for unsafe levels of contamination.
FDA RegulationExposure to Heat During Storage Causes Zantac Contamination
Benjamin Duong · January 14, 2020
Heat is the culprit causing carcinogenic NDMA contamination in Zantac, according to recent testing by Emery Pharma. A citizen petition requesting a total suspension of ranitidine products has been submitted to the FDA.
NewsMore Companies Pull Heartburn Meds to Participate in FDA Ranitidine Recall
James Parker · January 13, 2020
Appco Pharma and Denton Pharma have voluntarily recalled generic versions of Zantac (ranitidine) to align with the FDA's efforts to remove drugs from circulation that may contain more than 96 nanograms of NDMA per million nanograms of ranitidine.
FDA Regulation5 Alternatives to Zantac
Benjamin Duong · January 7, 2020
What are the alternative options to treat heartburn and related conditions? Here are 5 medications to take instead of Zantac.
Health FeaturesFDA Wants Recall of Zantac and Axid Amid Cancer Concern
Carah Wertheimer · November 5, 2019
Zantac, a commonly used heartburn medication, can contain the carcinogenic toxin NDMA, prompting the FDA to issue a voluntary recall.
FDA RegulationResearchers Link Heartburn Medications to Higher Risk of Gut Infection
Ashley Lombardo · January 11, 2017
New studies link acid reflux drugs to infection. PPI risks also include CKD, magnesium deficiency, dementia, bone loss and heart attacks.
Research + FindingsShowing All Results for “Zantac”
(25 results found)
FDA Regulation
More Recalls Issued for Diabetes Drug Metformin
October 15, 2020
FDA Regulation
FDA Issues Guidance on Drug Impurities
September 8, 2020
News
Drug Companies Investigated for Possible Failure to Disclose Zantac Cancer Risks
September 1, 2020
Legal Developments
California Attorneys Seek to Consolidate Zantac Lawsuits
June 12, 2020
Research + Findings
Pepcid Shows Promise Against COVID-19
May 28, 2020
News
Zantac and Ranitidine Products Removed from U.S. Market
April 1, 2020
Legal Developments
Corporations Accused of Allowing Excess NDMA in Zantac MDL
March 4, 2020
News
Canada Faces a Zantac Alternatives Shortage
February 11, 2020
Health Features
5 Powerful Quotes About Patient Safety by Congresswoman Rosa DeLauro
January 28, 2020
Legal Developments
Boynton Beach Zantac Lawsuit Filed by Local Woman
January 15, 2020
FDA Regulation
FDA Metformin Probe Investigates Potential NDMA Hazard
January 8, 2020
News
Exposure to Heat During Storage Causes Zantac Contamination
January 14, 2020
FDA Regulation
More Companies Pull Heartburn Meds to Participate in FDA Ranitidine Recall
January 13, 2020
Health Features
5 Alternatives to Zantac
January 7, 2020
FDA Regulation
FDA Wants Recall of Zantac and Axid Amid Cancer Concern
November 5, 2019
Research + Findings
Researchers Link Heartburn Medications to Higher Risk of Gut Infection
January 11, 2017